Dr Brian McNamee AO has executive experience in the biopharmaceutical industry, with a focus on strategy and creating long-term shareholder value. He also has global perspective and understanding of long-term capital projects in the pharmaceutical industry, with proven health, safety, environment and corporate responsibility.
Dr McNamee was a senior advisor to private equity group Kohlberg Kravis Roberts. He has also pursued a number of private equity and interests in small cap healthcare companies, and in 2014 served on the panel of the Australian Government's Financial System Inquiry.
In 2009, he was made an Officer of the Order of Australia for services to business and commerce.